Skip to content
Tech Pulse Blog

The Zimbabwean Government Turns Down ‘Lopsided’ American Healthcare Assistance Agreement Over Data Concerns

Health aid illustration
The offered US financial assistance was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has turned down a significant American health deal worth 367 million US dollars (272 million pounds) spanning five years because of the United States' request for confidential biological samples.

The decision came to light after a internal memorandum dated December was leaked, which showed President Emmerson Mnangagwa believed the deal was "unbalanced".

A government representative has since clarified that the US was seeking health data for research and profit while was not willing to guarantee the benefits from any future treatments.

"We are forced to start the difficult and regrettable process of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has urged continued negotiations to find a agreement agreeable to both sides so the country's vital HIV treatment initiative can be sustained.

Broader Implications

This rejection comes after a similar situation in neighbouring Kenya, where a court suspended a related health funding agreement after legal challenges were filed about the safety of Kenyans' health data.

Since resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).

USAID had managed aid for the US government, but Trump stated its spending was "inefficient" and his government was pursuing direct bilateral agreements to enhance openness and accountability.

Based on reports, Sixteen African countries have to date agreed to similar health pacts, representing over $18.3bn of fresh investment.

Specifics of the Rejected Deal

The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this partnership might have yielded extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on HIV treatment via American-funded initiatives," Tremont said.

However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".

"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, with no corresponding promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.

"Put simply, our nation would supply the basic resources for medical research with no certainty that the final treatments would be available to our population should a new pandemic arise."

National Interest and International Frameworks

He also pointed out that the American exit from the global health body and its push of one-on-one health agreements were disrupting systems previously established through the global organization.

Mangwana cited its Pathogen Access and Benefit Sharing system created to manage future pandemics.

"This system is designed to ensure that when a nation provides its samples, the benefits – including vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to create them."

The government's concerns regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We encourage continued discussions with our US partners on how future collaboration might be designed in a way that respects the independence and dignity of each country."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but urged that talks must proceed considering a large portion of the country's Aids initiatives relied on foreign aid.

"If specific concerns exist, including those involving data governance or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," it commented.

The halted deal highlights the complex tensions between receiving much-needed international aid and safeguarding local interests in an increasingly data-driven world.

The writer

Christine Mills

A digital strategist and tech enthusiast with over a decade of experience in analyzing emerging technologies and their impact on society.

Tech Pulse Blog

Type to search articles.